Navigation Links
Roche Women Honored as 2009 TWIN Awardees
Date:5/1/2009

NUTLEY, N.J., May 1 /PRNewswire/ -- Three Roche employees were recognized for their significant contributions to industry in New Jersey at the 2009 TWIN Awards Dinner held April 30, 2009. Honored were Nancy Shore DiLella, J.D., senior counsel and managing attorney; Theresa Martinez, marketing director for the leading hepatitis C treatment, Pegasys(R) (peginterferon alfa-2a); and Linda Lee-Mathieson, Director, Clinical Management, Pharma Development Operations.

"These individuals are exceedingly deserving of this recognition. They have made outstanding contributions to Roche, to the pharmaceutical industry as a whole and to the health and quality of life of countless people," said George Abercrombie, president and CEO of Hoffmann-la Roche Inc. "We are very proud to have them join the 82 Roche pharmaceutical employees recognized since TWIN began 35 years ago."

TWIN, which stands for Tribute to Women and INdustry, is sponsored by the YWCA of Bergen County to recognize women who have achieved responsible managerial, executive or professional positions and have made noteworthy contributions to their industries.

The Awardees

Nancy Shore DiLella, J.D., is senior counsel and managing attorney in the Corporate Law group, responsible for managing two legal teams, a regulatory legal team and the litigation group. She provides counsel on a myriad of legal issues involving products, commercial operations, functional areas, and litigation matters. DiLella has been instrumental in developing a variety of corporate policies and processes to help ensure compliance with federal and state laws and regulations, and she has played a major role in advising the company on complex commercial and government pricing issues.

"I am proud of the contributions Roche has made in the health care arena, and it has been a privilege for me to play a small role in it
'/>"/>

SOURCE Hoffmann-La Roche Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Rochester Medical Reports Second Quarter Results
2. Sanofi-Aventis and Roche/Chugais Drugs Will Dominate the Indian Colorectal Cancer Drug Market Through 2013
3. Roche Announces New Co-pay Program in Pennsylvania that Makes It Easier for Patients with Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips
4. Roche Announces New Co-pay Program in Florida that Makes It Easier for Patients with Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips
5. Roche Announces New Co-Pay Program in California That Makes it Easier for Patients With Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips
6. Rochester Medical Announces Second Quarter 2009 Earnings Conference Call April 30, 2009
7. Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement
8. Roche Completes Acquisition of Genentech
9. The College of New Rochelle School of Nursing Receives $50,000 Grant From the Verizon Foundation for Telenursing Pilot Program
10. Roche Increases Offer Price for Genentech Shares to US$ 93.00 per Share and Extends Offer
11. Rochester Medical Renews Share Repurchase Activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... (PRWEB) September 19, 2014 The ... important partnership with the National Fire Protection Association ... The collaboration, formalized today in a Memorandum of ... Members, factories, workers and other stakeholders with information, ... help protect the health and safety of workers ...
(Date:9/19/2014)... Lipitor lawsuits ( http://www.thelipitorlawsuit.com/ ) ... develop Type 2 diabetes continue to move forward in ... Court, District of South Carolina, Bernstein Liebhard LLP reports. ... 2014, discovery is underway and moving forward in the ... Inc., the manufacturer of Lipitor, has produced millions of ...
(Date:9/19/2014)... MetroMD, a leading anti-ageing clinic has called its ... health. This therapy has grown tremendously across USA in the ... safe and dependable. It has far reaching benefits for ageing ... a very healthy and active lifestyle even beyond their middle ... senior therapist at MetroMD said, “HGH or Human Growth hormones ...
(Date:9/19/2014)... intact cells to treat and cure disease is ... is hindered by the inability of doctors and scientists ... these cells in patients without resorting to invasive procedures, ... 17 in the online journal Magnetic Resonance in ... Diego School of Medicine, University of Pittsburgh and elsewhere ...
(Date:9/19/2014)... 2014 "I have difficulty putting in ... to stretching the skin around my eyes during the ... me to design a more convenient method of performing ... provides a quicker, easier, more sanitary method of putting ... this task manually, saves time and effort, and helps ...
Breaking Medicine News(10 mins):Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 3Health News:Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2Health News:A better way to track emerging cell therapies using MRIs 2
... to open its 100-bed super-specialty hospital in Oman by the ... of Oman newspaper quoted Apollo Medical Centre (AMC) managing director ... first of its kind in the private sector in Oman. ... between super-specialty hospitals and polyclinics in the Gulf nation. ...
... today told captains of the bio-tech industry that generation of ... the sector, may not be possible. // ,'One ... far cry,' Sibal said at the inauguration of 'Bio 2006', ... ,Unlike the IT sector based on services, biotechnology sector ...
... to the researcher Steve Allen of Stanford University in California, ... fuel-efficient engines in the universe, from a research//. ... billion miles (1.6 billion km) on a gallon (4.5 litres) ... gas of the galaxies, can measure hundreds or even thousands ...
... Age-related Macular Degeneration (AMD) is one of the primary causes ... the disease may partly depend upon his diet.// The quality ... rather than the quantity, according to a research led ... and Vision Research , at Tufts University. Their findings ...
... calpain can play a key role in regulating cell death, ... by these scientists //that calpain may be used to promote ... prevent cell death such as in neuronal cells in ... a Professor of Pathology and Molecular Medicine with the Cancer ...
... for the elderly was planned as a new deal for ... //for everyone in old age. But now this policy is ... councils are alleging that they have already run out of ... was reported that more than 200 pensioners were denied their ...
Cached Medicine News:Health News:Quality Of Dietary Carbohydrates May Determine Quality Of Eye Sight 2Health News:Quality Of Dietary Carbohydrates May Determine Quality Of Eye Sight 3Health News:Protein’s role in regulating cell death sets direction for Alzheimer’s, Parkinson’s and cancer resea 2
(Date:9/19/2014)... LUBBOCK, Texas , Sept. 19, 2014 Kiromic, ... today the addition of Kent Hance , the former ... vice chairman. Hance retired as chancellor in July 2014, after ... pleased to announce that Kent Hance , the most ... joined the Kiromic team not only as an investor, but ...
(Date:9/19/2014)... Sept. 19, 2014  The board of directors of ... quarterly cash dividend of $0.42 per share.  ... to stockholders of record at the close of business ... is a global, research-based biopharmaceutical company formed in 2013 ... use its expertise, dedicated people and unique approach to ...
(Date:9/19/2014)... , September 19, 2014 ... Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture ... Users (Hospitals), Advanced technologies - Global Forecast to ... is poised to reach $19,786.3 Million by 2019 ... of 6.8% from 2014 to 2019. ...
Breaking Medicine Technology:Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 4
Cormet Hip Resurfacing is a conservative treatment for the young, active, high demand patient group which conserves femoral bone, provides anatomical bone loading, eliminates polyethylene and is desi...
...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
Medicine Products: